Hemoglobin Measured by MASIMO SpHb™ Device and Laboratory Measurement

Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

NCT00548860 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Free α-hemoglobin Pool in the Red Blood Cells : Prognostic Marker and Severity Index in Thalassemic Syndromes

NCT02855957 ·Status: COMPLETED ·Phase: NA

Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations

NCT01911871 ·Status: COMPLETED

GenoMed4ALL: Improving SCD Classification and Prognosis by AI

NCT06019208 ·Status: UNKNOWN

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia

NCT00703937 ·Status: COMPLETED ·Phase: PHASE3

Interest of Reticulocyte Haemoglobin Content (RET-he) in Management of Functional Anemia for Patient With Solid Tumor

NCT03656172 ·Status: COMPLETED

The Impact of Red Packed Cells Transfusion on the Main Biological Markers to Determine the Etiology of Anemias

NCT01409967 ·Status: COMPLETED

Different Iron Supplements for Prevention of Anemia in Pregnancy

NCT02487719 ·Status: UNKNOWN ·Phase: PHASE4

Synthetic Generation of Hematological Data Over Federated Computing Frameworks: SCD Use Case

NCT06794281 ·Status: ACTIVE_NOT_RECRUITING

Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency

NCT01414374 ·Status: COMPLETED ·Phase: PHASE3

Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)

NCT05289700 ·Status: UNKNOWN ·Phase: PHASE3

Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

NCT02526121 ·Status: COMPLETED ·Phase: NA

Hereditary Spherocytosis and Vascular Function

NCT04451785 ·Status: COMPLETED ·Phase: NA

Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels

NCT04263571 ·Status: UNKNOWN

Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research

NCT03876821 ·Status: COMPLETED

Detection of Anemizations in Primary Care.

NCT04757909 ·Status: UNKNOWN ·Phase: NA

Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"

NCT06735625 ·Status: RECRUITING ·Phase: NA

Outcomes of Patient Blood Management in Severely Anemic Patients

NCT06345417 ·Status: NOT_YET_RECRUITING

Study of a Deformability Parameter of Red Blood Cell

NCT05850156 ·Status: NOT_YET_RECRUITING

Oxidative Stress and Iron Overload in Patient With Abnormal Haemoglobinopathy

NCT05586932 ·Status: UNKNOWN

Heavy Menstrual Bleeding and Iron Deficiency Anemia

NCT05079815 ·Status: UNKNOWN

Total Splenectomy vs Partial Splenectomy in Non-malignant Hemoglobinopathies : Study Comparing the Effectiveness

NCT05184647 ·Status: UNKNOWN

Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding

NCT01307007 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Impact of Disease on Quality of Life, Education and Socio-professional Integration of Adults and Parents of Children Living with Sickle- Cell Disease in France

NCT04413539 ·Status: COMPLETED

Lipid Balance in Adult Sickle Cell Patients

NCT05780775 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA